Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Haina Pharmaceutical Co., Ltd. is a specialized Chinese pharmaceutical company based in Harbin, focused on the development and manufacturing of external application medicines. Established in 1996, the company operates in close coordination with its sister entity, Heilongjiang Tianlong Pharmaceutical, sharing a 100,000-square-meter GMP-certified manufacturing base. Its product portfolio includes over 100 specifications across dosage forms such as suppositories, lotions, eye drops, sprays, and creams, targeting therapeutic areas like gynecology, dermatology, and ENT. Key commercial products include Policresulen Vaginal Suppository and Stomatitis Spray, which are distributed throughout China and exported to over 20 countries. The company emphasizes innovation in topical drug delivery and maintains six advanced production lines to support its global supply chain. With a workforce of over 500 employees, Haina Pharmaceutical continues to invest in R&D to develop next-generation breakthrough formulations for topical therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Haina Pharmaceutical.